Estonia Pharmaceuticals & Healthcare Q1 2021

Estonia Pharmaceuticals & Healthcare Q1 2021

Key View:

We hold an improved outlook for health spending in Estonia as greater resources are allocated to the healthcare systemamid the coronavirus pandemic. However, existing shortages of vital medicines will continue to impact healthcare outcomes forpatients in Estonia. The country’s drug shortages will only be made worse by the pandemic, in addition to the newly implementedpharmacy ownership reforms, as some pharmacies close due to either staff quarantining. Nonetheless, we maintain a relativelypositive long-term outlook for medicine spending growth as healthcare funding continues to increase.


Key View
Estonia Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Grindeks
Estonia Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook